Experts: Home Testing Not Likely a 'Game Changer' in the Fight Against HIV

October 8th, 2012
According to the authors of a new editorial being published early online in Annals of Internal Medicine, the new over-the-counter, home-based HIV test, OraQuick, is not likely to lower the barriers to care or reduce HIV transmission.

With its relatively high cost, the test is likely to attract affluent persons at low risk for infection, persons with very recent high-risk exposures, or those with diagnosed HIV seeking to find out if treatment has reversed their seropositivity. The authors, both renown HIV experts, recommend that physicians counsel their patients about the use, misuse, and anticipated benefits of home HIV testing.

According to the authors, it is important for patients to understand both the benefits and the limitations of the test so they may make informed decisions about monitoring their HIV status and engaging sexual partners. Ultimately, home testing is not a substitute for routine HIV screening in a professional health care setting, and is unlikely to help identify the 235,000 Americans who are still unaware of their HIV infection.

Note: For an embargoed PDF of this editorial, please contact Angela Collom. To interview the lead author, Dr. David Paltiel, please contact Helen Dodson at helen.dodson@yale.com or 203-436-3984.

Provided by American College of Physicians

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

SARS-like virus claims new life in Saudi

A man who had contracted the coronavirus has died in Saudi Arabia, raising the death toll in the kingdom from the SARS-like virus to 17, the health ministry announced on its website on Wednesday.

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

NASA: Austin, calling Austin. 3-D pizzas to go

(Phys.org) —The idea of living with 3-D printed food is neither unthinkable nor new; designers and futurists have been looking to 3-D printing as food's next frontier. In 2012, there was news that the Thiel ...